1. A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer. (5th August 2019) Authors: Segar, Jennifer M.; Reed, Darien; Stopeck, Alison; Livingston, Robert B.; Chalasani, Pavani Journal: Oncologist Issue: Volume 24:Number 12(2019) Page Start: 1512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer. (26th September 2014) Authors: Chalasani, Pavani; Stopeck, Alison; Clarke, Kathryn; Livingston, Robert Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor‐Positive Metastatic Breast Cancer. (26th September 2014) Authors: Chalasani, Pavani; Stopeck, Alison; Clarke, Kathryn; Livingston, Robert Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. (2nd January 2020) Authors: Stopeck, Alison; Brufsky, Adam; Kennedy, Lisa; Bhatta, Sumi; Bhowmik, Debajyoti; Buchanan, Jacqueline; Despiegel, Nicolas; Hechmati, Guy Journal: Journal of medical economics Issue: Volume 23:Number 1(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hypocalcaemia in patients with metastatic bone disease treated with denosumab. Issue 13 (September 2015) Authors: Body, Jean-Jacques; Bone, Henry G.; de Boer, Richard H.; Stopeck, Alison; Van Poznak, Catherine; Damião, Ronaldo; Fizazi, Karim; Henry, David H.; Ibrahim, Toni; Lipton, Allan; Saad, Fred; Shore, Neal; Takano, Toshimi; Shaywitz, Adam J.; Wang, Huei; Bracco, Oswaldo L.; Braun, Ada; Kostenuik, Paul J. Journal: European journal of cancer Issue: Volume 51:Issue 13(2015:Sep.) Page Start: 1812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pain outcomes in patients with advanced breast cancer and bone metastases. Issue 4 (5th September 2012) Authors: Cleeland, Charles S.; Body, Jean‐Jacques; Stopeck, Alison; von Moos, Roger; Fallowfield, Lesley; Mathias, Susan D.; Patrick, Donald L.; Clemons, Mark; Tonkin, Katia; Masuda, Norikazu; Lipton, Allan; de Boer, Richard; Salvagni, Stefania; Oliveira, Celia Tosello; Qian, Yi; Jiang, Qi; Dansey, Roger;... Journal: Cancer Issue: Volume 119:Issue 4(2013) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pathophysiology of tumour-induced microangiopathic haemolytic anaemia. (7th January 2016) Authors: Chalasani, Pavani; Segar, Jennifer M; Marron, Marilyn; Stopeck, Alison Journal: BMJ case reports Issue: Volume 2016 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. Issue 1 (December 2016) Authors: Martinez, Jessica; Chalasani, Pavani; Thomson, Cynthia; Roe, Denise; Altbach, Maria; Galons, Jean-Philippe; Stopeck, Alison; Thompson, Patricia; Villa-Guillen, Diana; Chow, H-H. Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗